Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

ARS Pharmaceuticals, Inc.

CIK 1671858Updated Nov 16, 2026

Name history
Silverback Therapeutics, Inc. · through Nov 8, 2022

SPRY price & chart

Provider market data

Loading TradingView…

NASDAQ:SPRY on TradingView ↗

TradingView · Data may be delayed

About the company

ARS Pharma is a biopharmaceutical company developing and commercializing treatments that help at-risk patients and their caregivers treat and prevent severe allergic reactions. The company is commercializing neffy® (epinephrine nasal spray), the only needle-free epinephrine approved by the U.S. Food & Drug Administration, for the emergency treatment of Type I allergic reactions, including anaphylaxis, in adults and children weighing 33 lbs. (15 kg) or more. In the European Union, the product is marketed as EURneffy®, the only needle-free epinephrine product authorized by the European Commission, for the emergency treatment of allergic reactions, including anaphylaxis, in adults and children four years of age and older weighing 15 kg or more. The product is also marketed as 优敏速® in China. Leveraging its intranasal technology, ARS Pharma is also developing ARS-2, currently in a Phase 2b clinical trial, as a potential first treatment for acute breakthrough flares of chronic spontaneous urticaria (CSU). For more information, visit www.ars-pharma.com and follow us on LinkedIn.

8-K · 2026-11-05 · 0001193125-26-449748

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Recent filings

  1. 10-Q filing

    10-Q · 2026-11-05 · 0001193125-26-449778

  2. Results of Operations and Financial Condition

    Items 2.02, 9.01

    8-K · 2026-11-05 · 0001193125-26-449748

  3. 4 filing

    4 · 2026-11-04 · 0001475990-26-000009

  4. 3 filing

    3 · 2026-11-04 · 0001475990-26-000008

  5. 144 filing

    144 · 2026-09-11 · 0001950047-26-009340

Show 5 more recent filings
  1. 144 filing

    144 · 2026-09-11 · 0001950047-26-009329

  2. 144 filing

    144 · 2026-09-04 · 0001950047-26-009120

  3. 144 filing

    144 · 2026-09-03 · 0001950047-26-009066

  4. 144 filing

    144 · 2026-09-02 · 0001950047-26-009041

  5. 144 filing

    144 · 2026-09-01 · 0001950047-26-008961

Financials

FY 2025 · USD
Revenue84,278,000USD · FY 2025
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

Net income-171,298,000USD · FY 2025
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

Operating income-179,448,000USD · FY 2025
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

Diluted EPS-1.74USD per share · FY 2025
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD372,803,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

217,601,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

249,495,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

313,472,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

221,966,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

287,571,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

327,318,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

227,583,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

327,652,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

351,153,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

233,188,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

281,435,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Property, Plant and Equipment, NetUSD1,209,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

843,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

2,085,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

1,075,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

636,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

2,285,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

1,075,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

616,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

2,465,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

1,029,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

574,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

329,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Intangible Assets, Net (Excluding Goodwill)USD14,729,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

7,500,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

13,900,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

12,972,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

—14,176,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

7,241,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

—14,452,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

7,371,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

——
Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD59,557,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

39,657,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

8,163,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

51,540,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

36,626,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

24,321,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

39,864,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

56,006,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

41,317,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

50,817,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

70,971,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

210,518,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD36,451,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

773,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

46,839,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

25,126,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

—28,662,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

9,303,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

—25,347,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

8,175,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

——
Inventory, NetUSD21,427,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

715,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

30,734,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

22,112,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

—32,038,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

7,270,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

—31,422,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

5,212,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

——
Assets, CurrentUSD338,863,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

208,789,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

211,510,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

281,436,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

220,738,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

245,236,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

303,860,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

226,241,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

284,896,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

334,295,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

231,726,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

277,700,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD6,421,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

2,677,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

9,137,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

7,442,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

1,994,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

6,788,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

11,560,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

2,609,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

6,194,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

6,886,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

3,366,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

3,319,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD1,439,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

92,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

—1,564,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

146,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

—72,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

198,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

—37,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

250,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

445,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD225,148,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

16,623,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

236,983,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

121,151,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

6,725,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

226,263,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

98,344,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

3,715,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

213,394,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

94,355,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

2,428,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

8,549,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD0
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

0
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

0
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

0
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

0
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

0
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

0
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

0
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

0
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

0
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

0
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

0
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Common Stock, Value, IssuedUSD10,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

10,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

10,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

10,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

10,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

10,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

10,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

10,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

10,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

10,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

10,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

9,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Additional Paid in CapitalUSD400,931,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

373,868,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

430,202,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

394,485,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

369,487,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

416,615,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

386,137,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

365,577,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

408,726,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

379,873,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

362,004,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

349,408,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-253,279,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

-173,239,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

-417,560,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

-202,128,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

-154,111,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

-355,221,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

-157,245,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

-141,595,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

-294,603,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

-123,305,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

-131,303,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

-76,938,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-7,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

339,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

-140,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

-46,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

-145,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

-96,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

72,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

-124,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

125,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

220,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

49,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

407,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD147,655,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

200,978,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2024-09-30

12,512,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

192,321,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2025-06-30

215,241,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2024-06-30

61,308,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

228,974,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2025-03-31

223,868,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2024-03-31

114,258,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

256,798,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

230,760,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

272,886,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Liabilities and EquityUSD372,803,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

217,601,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

249,495,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

313,472,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

221,966,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

287,571,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

327,318,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

227,583,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

327,652,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

351,153,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

233,188,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

281,435,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD50,877,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

16,623,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

60,863,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

45,599,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

6,725,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

49,612,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

27,622,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

3,715,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

39,145,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

23,440,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

2,391,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

5,444,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Operating Lease, Liability, CurrentUSD583,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

102,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

—589,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

160,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

—73,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

217,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

—42,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

237,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

230,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Accounts Payable, CurrentUSD8,382,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

8,276,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

5,198,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

15,559,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

3,272,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

4,705,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

4,095,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

839,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

5,725,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

9,870,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

759,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

1,659,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD949,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

0
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

—1,072,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

0
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

——0
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

—0
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

37,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

251,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Additional Financial Items
Deferred Tax Liabilities, NetUSD————————394,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

138,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

112,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

249,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Long-term DebtUSD96,229,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

—96,676,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

——96,522,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

——96,374,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

———
Short-term InvestmentsUSD228,652,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

164,967,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

As of 2024-09-30

135,682,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

188,590,000
Source

10-Q · 2025-08-13 · 0000950170-25-107618

As of 2025-06-30

182,118,000
Source

10-Q · 2024-08-06 · 0000950170-24-091776

As of 2024-06-30

176,648,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

235,863,000
Source

10-Q · 2025-05-14 · 0000950170-25-070900

As of 2025-03-31

167,626,000
Source

10-Q · 2024-05-09 · 0000950170-24-056967

As of 2024-03-31

203,669,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

263,205,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

157,389,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

63,863,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization———————
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

—
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

—
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

—
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

—
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

—
Share-based Payment Arrangement, Noncash ExpenseUSD——5,689,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

3,591,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

12,395,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

5,371,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

7,423,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

5,298,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

22,095,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

14,534,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

9,235,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

5,843,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD——————839,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

1,128,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

17,205,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

8,175,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

——
Increase (Decrease) in InventoriesUSD——————294,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

8,449,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

21,986,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

5,945,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

——
Deferred Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

——
Net Cash Provided by (Used in) Operating ActivitiesUSD——————-44,946,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

-40,742,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

-170,866,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

13,548,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

-59,266,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

-40,078,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————27,791,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

29,064,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

56,768,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

-106,101,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

-87,180,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

-199,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————0
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

91,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

339,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

563,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

175,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

199,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————159,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

725,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

104,598,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

72,399,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

6,899,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

190,732,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-16,996,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

-10,953,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

-9,500,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

-20,154,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

-139,547,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

150,455,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——59,557,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2025-09-30

39,657,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

As of 2024-09-30

8,163,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2026-06-30

51,540,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

As of 2025-06-30

24,321,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2026-03-31

39,864,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

As of 2025-03-31

41,317,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

As of 2025-12-31

50,817,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

As of 2024-12-31

70,971,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

As of 2023-12-31

210,518,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD——————2,293,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

2,452,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

———
Income Taxes Paid, NetUSD————————200,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

———
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD———3,591,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

2024-07-01 to 2024-09-30

—————14,534,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

9,235,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

5,843,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Amortization of Intangible AssetsUSD——200,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

300,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

100,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

300,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

100,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

800,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

100,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

——
DepreciationUSD—————————79,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

73,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

—
Depreciation, Amortization and Accretion, NetUSD———————————319,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Gain (Loss) on InvestmentsUSD——————————0
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

-140,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——————————47,284,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

18,456,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————-80,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

288,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Inventory Write-downUSD————————2,160,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to ParentUSD——-51,151,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

-19,128,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

-62,339,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

-44,883,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

-60,618,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

-33,940,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

-171,298,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

7,998,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

-54,365,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

-34,682,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD———————————834,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Operating Costs and ExpensesUSD———406,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

2024-07-01 to 2024-09-30

—————2,066,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

1,796,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

—
Operating ExpensesUSD——85,693,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

23,816,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

95,123,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

63,331,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

82,826,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

45,150,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

263,726,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

92,232,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

67,550,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

36,832,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——2,041,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

2,620,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

-874,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

2,731,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

-473,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

3,237,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

8,070,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

11,369,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

13,155,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

974,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——32,501,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

2,068,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

33,658,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

15,717,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

22,681,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

7,973,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

84,278,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

89,149,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

30,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

1,316,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Selling, General and Administrative ExpenseUSD——74,751,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

19,281,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

77,579,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

54,312,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

72,204,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

41,104,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

230,122,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

71,675,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

940,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

—
Operating Income (Loss)USD——-53,192,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

-21,748,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

-61,465,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

-47,614,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

-60,145,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

-37,177,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

-179,448,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

-3,083,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

-67,520,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

-35,516,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——2,041,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

2,620,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

-874,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

2,731,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

-473,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

3,237,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

8,070,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

11,369,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

13,155,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

974,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD————————-171,378,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

8,286,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

——
Income Tax Expense (Benefit)USD————————-80,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

288,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-51,151,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

-19,128,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

-62,339,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

-44,883,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

-60,618,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

-33,940,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

-171,298,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

7,998,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

-54,365,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

-34,682,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.52
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

-0.2
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

-0.63
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

-0.46
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

-0.61
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

-0.35
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

-1.74
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

0.08
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

-0.57
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

-0.87
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.52
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

-0.2
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

-0.63
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

-0.46
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

-0.61
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

-0.35
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

-1.74
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

0.08
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

-0.57
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

-0.87
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——98,807,600
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

97,032,331
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

99,312,526
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

98,361,771
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

99,296,408
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

98,060,636
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

98,566,481
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

96,936,661
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

95,215,322
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

39,956,043
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——98,807,600
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

97,032,331
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

99,312,526
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

98,361,771
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

99,296,408
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

98,060,636
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

98,566,481
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

102,390,828
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

95,215,322
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

39,956,043
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Additional Financial Items
Amortization of Intangible AssetsUSD——200,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

300,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

100,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

300,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

100,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

800,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

100,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

——
Current Income Tax Expense (Benefit)USD————————-80,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

288,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

——
Depreciation, Depletion and Amortization, NonproductionUSD——————397,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

280,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

1,367,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

100,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

100,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

—
Gain (Loss) on InvestmentsUSD——————————0
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

-140,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——————————47,284,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

18,456,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-171,372,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

———
Nonoperating Income (Expense)USD———————————834,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Operating Costs and ExpensesUSD———406,000
Source

10-Q · 2024-11-13 · 0000950170-24-125924

2024-07-01 to 2024-09-30

—————2,066,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

1,796,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

—
Operating ExpensesUSD——85,693,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

23,816,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

95,123,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

63,331,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

82,826,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

45,150,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

263,726,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

92,232,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

67,550,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

36,832,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——2,751,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2025-07-01 to 2025-09-30

4,423,000
Source

10-Q · 2025-11-10 · 0001193125-25-273111

2024-07-01 to 2024-09-30

4,698,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2026-04-01 to 2026-06-30

4,035,000
Source

10-Q · 2026-08-13 · 0001193125-26-349140

2025-04-01 to 2025-06-30

4,336,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2026-01-01 to 2026-03-31

2,952,000
Source

10-Q · 2026-05-15 · 0001193125-26-225142

2025-01-01 to 2025-03-31

13,181,000
Source

10-K · 2026-03-09 · 0001193125-26-097478

2025-01-01 to 2025-12-31

19,580,000
Source

10-K · 2025-03-20 · 0000950170-25-042320

2024-01-01 to 2024-12-31

20,266,000
Source

10-K · 2024-03-21 · 0000950170-24-034689

2023-01-01 to 2023-12-31

18,376,000
Source

10-K · 2023-03-23 · 0000950170-23-009491

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

spry-ex99_1.htm · 8-K · 2026-11-05

Exhibit 99.1 ARS Pharma Reports Business Highlights and Third Quarter 2026 Financial Results Total Q3 revenue of $37.7 million, including $33.4 million in U.S. net product revenue for neffy® neffy U.S. market share reached 5% overall and 9% in field-targeted accounts, supporting the company’s updated targeted provider commercial strategy Reduced SG&A spend reflected in Q3 operating expenses; reaffirm path to cash flow breakeven by year-end 2027 Leadership team strengthened with appointments…

8-K · 2026-11-05 · 0001193125-26-449748

Read attachment ↗
spry-ex99_1.htm · 8-K · 2026-08-13

EX-99.1 2 spry-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results $26.2 million in U.S. neffy® net product revenue in Q2 2026; total U.S. epinephrine market share for Type 1 allergies of 5% and 8% share within field-targeted accounts Commercial investment realigned toward targeted provider engagement, significantly reducing total operating expenses for 2H 202…

8-K · 2026-08-13 · 0001193125-26-349127

Read attachment ↗
spry-ex99_1.htm · 8-K · 2026-05-15

EX-99.1 2 spry-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update Q1 2026 total revenue of $22.7 million including neffy U.S. net product revenue of $17.5 million CVS Caremark proposal in final stages of approval process; definitive update anticipated in early June Sales force expansion to 148 representatives completed Phase 2b CSU study interim population fully enrolled, and on track for Q4 2026 readout Confer…

8-K · 2026-05-15 · 0001193125-26-225055

Read attachment ↗
spry-ex99_2.htm · 8-K · 2026-05-15

EX-99.2 3 spry-ex99_2.htm EX-99.2 May 2026 Corporate Presentation neffy - the transformative needle-free solution for severe allergic reactions Exhibit 99.2 NASDAQ: SPRY Forward-looking statements Statements in this presentation that are not purely historical in nature are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation include, without limitation, statements regarding: the potential ma…

8-K · 2026-05-15 · 0001193125-26-225055

Read attachment ↗
spry-ex99_1.htm · 8-K · 2026-03-09

EX-99.1 2 spry-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization neffy delivers $72.2 million of U.S. net product revenue in first full year Intranasal epinephrine platform advances with Phase 2b CSU data expected mid-2026 Strong balance sheet of $245.0 million in cash, cash equivalents and short-term investments supports operating plan through anticipa…

8-K · 2026-03-09 · 0001193125-26-097467

Read attachment ↗
spry-ex99_2.htm · 8-K · 2026-03-09

EX-99.2 3 spry-ex99_2.htm EX-99.2 March 2026 Corporate Presentation neffy - the transformative needle-free solution for severe allergic reactions Exhibit 99.2 NASDAQ: SPRY Forward-looking statements Statements in this presentation that are not purely historical in nature are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation include, without limitation, statements regarding: the potential …

8-K · 2026-03-09 · 0001193125-26-097467

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.